IOIC’s had on 12 September 2017 entered into a definitive sale and purchase agreement with Koninklijke Bunge B.V. (KBBV) for the disposal of 70% stake held in Loders Crocklaan Group B.V. (Loders) for a total cash consideration of USD595m (RM2.54m) plus EUR297m (RM1.51m).
As part of the conditions in SPA, prior to the completion of the proposed disposal, IOIC is required to complete an internal restructuring exercise, which involves Loders acquiring all of IOIC’s equity interest in 1) IOI Lipid Enzymtec Sdn Bhd (IOILE), a wholly-owned subsidiary of IOIC, and 2) IOI Edible Oils (HK) Limited (IEO HK), a wholly-owned subsidiary of IOIC.
According to the announcement, the rationale of the proposed disposal is to 1) allow Loders to leverage on the size of Bunge’s operations by tapping into Bunge’s expertise and extensive geographical coverage, 2) unlock or monetize IOIC investment in Loders Group with expected gain of RM2,505.80m, and 3) provide financial flexibility for the Group to undertake potential future investments, pare down borrowings of IOIC Group and enhanced shareholder’s value which include vis cash dividend distribution to be undertaken by IOIC.
Source: BIMB Securities Research - 13 Sept 2017
Chart | Stock Name | Last | Change | Volume |
---|
Created by kltrader | Nov 12, 2024
Created by kltrader | Nov 11, 2024
Created by kltrader | Nov 11, 2024
Created by kltrader | Nov 11, 2024
Created by kltrader | Nov 08, 2024